InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sunshine Biopharma Inc.

SBFM Clue Score61
United States Fiscal year ends December CIK 0001402328
$0.34 -21.44% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.34 +204.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−1.0Net income−3.5Fiscal year 2017Revenue0.0Operating income−0.9Net income−1.0Fiscal year 2018Revenue0.0Operating income−1.2Net income−2.2Fiscal year 2019Revenue0.0Operating income−0.6Net income−1.7Fiscal year 2020Revenue0.1 +238.1%Operating income−0.6Net income−2.8Fiscal year 2021Revenue0.2 +219.9%Operating income−2.4Net income−12.4EPS, diluted−4.76Fiscal year 2022Revenue4.3 +1,802.4%Operating income−27.0Net income−26.7EPS, diluted−1.76Fiscal year 2023Revenue24.1 +454.4%Operating income−4.8Net income−4.5EPS, diluted−351.36Fiscal year 2024Revenue34.9 +44.7%Operating income−5.8Net income−5.1EPS, diluted−7.32Fiscal year 2025Revenue36.3 +4.1%Operating income−6.2Net income−6.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.0 0.0 0.0 0.1 0.2 4.3 24.1 34.9 36.3
Growth +238.1% +219.9% +1,802.4% +454.4% +44.7% +4.1%
Operating income −1.0 −0.9 −1.2 −0.6 −0.6 −2.4 −27.0 −4.8 −5.8 −6.2
Net income −3.5 −1.0 −2.2 −1.7 −2.8 −12.4 −26.7 −4.5 −5.1 −6.0
Growth
EPS, diluted n/a n/a n/a n/a n/a −4.76 −1.76 −351.36 −7.32 n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Gross margin47.7%Operating margin−3,037.9%Net margin−7,860.9%Free cash flow margin−2,351.5%Fiscal year 2020Gross margin63.8%Operating margin−807.8%Net margin−3,898.7%Free cash flow margin−922.1%Fiscal year 2021Gross margin48.4%Operating margin−1,068.2%Net margin−5,444.4%Free cash flow margin−800.8%Fiscal year 2022Gross margin39.0%Operating margin−621.3%Net margin−615.4%Free cash flow margin−125.2%Fiscal year 2023Gross margin34.6%Operating margin−19.9%Net margin−18.7%Free cash flow margin−36.8%Fiscal year 2024Gross margin30.6%Operating margin−16.7%Net margin−14.7%Free cash flow margin−40.7%Fiscal year 2025Gross margin33.8%Operating margin−17.2%Net margin−16.5%Free cash flow margin−15.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a 47.7% 63.8% 48.4% 39.0% 34.6% 30.6% 33.8%
Operating margin n/a n/a n/a −3,037.9% −807.8% −1,068.2% −621.3% −19.9% −16.7% −17.2%
Net margin n/a n/a n/a −7,860.9% −3,898.7% −5,444.4% −615.4% −18.7% −14.7% −16.5%
Free cash flow margin n/a n/a n/a −2,351.5% −922.1% −800.8% −125.2% −36.8% −40.7% −15.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−0.3Capital expenditure−0.0Free cash flow−0.3Fiscal year 2017Operating cash flow−0.5Capital expenditure−0.0Free cash flow−0.5Fiscal year 2018Operating cash flow−0.5Capital expenditure−0.0Free cash flow−0.5Fiscal year 2019Operating cash flow−0.5Capital expenditure−0.0Free cash flow−0.5Fiscal year 2020Operating cash flow−0.7Capital expenditure−0.0Free cash flow−0.7Fiscal year 2021Operating cash flow−1.8Capital expenditure0.0Free cash flow−1.8Fiscal year 2022Operating cash flow−5.2Capital expenditure−0.2Free cash flow−5.4Fiscal year 2023Operating cash flow−8.8Capital expenditure−0.1Free cash flow−8.9Buybacks−0.5Fiscal year 2024Operating cash flow−12.5Capital expenditure−1.7Free cash flow−14.2Buybacks−3.1Fiscal year 2025Operating cash flow−5.3Capital expenditure−0.2Free cash flow−5.5Buybacks0.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 −0.5 −0.5 −0.5 −0.7 −1.8 −5.2 −8.8 −12.5 −5.3
Capital expenditure −0.0 −0.0 −0.0 −0.0 −0.0 0.0 −0.2 −0.1 −1.7 −0.2
Free cash flow −0.3 −0.5 −0.5 −0.5 −0.7 −1.8 −5.4 −8.9 −14.2 −5.5
Growth
Buybacks n/a n/a n/a n/a n/a n/a n/a −0.5 −3.1 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.1Shareholders’ equity−0.2Fiscal year 2017Cash0.1Shareholders’ equity−0.6Fiscal year 2018Cash0.1Shareholders’ equity−0.1Fiscal year 2019Cash0.0Shareholders’ equity−0.7Fiscal year 2020Cash1.0Total debt0.9Net cash (debt)0.0Shareholders’ equity−1.0Fiscal year 2021Cash2.0Shareholders’ equity0.2Fiscal year 2022Cash21.8Shareholders’ equity21.6Fiscal year 2023Cash16.3Shareholders’ equity21.2Fiscal year 2024Cash9.7Shareholders’ equity23.5Fiscal year 2025Cash9.1Shareholders’ equity23.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.1 0.1 0.1 0.0 1.0 2.0 21.8 16.3 9.7 9.1
Total debt n/a n/a n/a n/a 0.9 n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a 0.0 n/a n/a n/a n/a n/a
Shareholders’ equity −0.2 −0.6 −0.1 −0.7 −1.0 0.2 21.6 21.2 23.5 23.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 0.0 0.0 0.0 0.1 0.2 4.3 24.1 34.9 36.3
Growth +238.1% +219.9% +1,802.4% +454.4% +44.7% +4.1%
n/a 0.0 0.0 0.0 0.0 0.1 2.6 15.8 24.2 24.1
n/a 0.0 0.0 0.0 0.0 0.1 1.7 8.3 10.7 12.3
Growth +352.4% +142.7% +1,434.0% +391.5% +27.9% +14.9%
0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.9 0.9 0.6
1.0 0.9 1.2 0.7 0.6 2.6 28.7 13.1 16.5 18.5
−1.0 −0.9 −1.2 −0.6 −0.6 −2.4 −27.0 −4.8 −5.8 −6.2
Growth
n/a n/a n/a n/a n/a −12.4 −26.5 −4.1 −5.4 −6.0
n/a n/a n/a n/a 0.0 0.0 0.2 0.4 −0.2 0.0
−3.5 −1.0 −2.2 −1.7 −2.8 −12.4 −26.7 −4.5 −5.1 −6.0
Growth
Per share
−0.01 −0.02 −0.71 −0.15 −2.73 −4.76 −1.76 −351.36 −7.32 −1.44
n/a n/a n/a n/a n/a −4.76 −1.76 −351.36 −7.32 n/a
Growth
424.9 43.6 3.0 10.9 1.0 2.6 15.2 0.0 0.7 4.2
n/a n/a n/a n/a n/a 2.6 15.2 0.0 0.7 n/a
Growth +481.2% −99.9% +5,371.7%

† The diluted share count jumps at 2022 and 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 247.7% a year over five years.
  • Operating margin is up 790.7 points on five years ago, at -17.2%.
  • A net loss in 10 of 10 years on file.